As the Novavax vaccine becomes approved by more and more countries, NVAX stock will likely climb in the near-to-medium term. More
Articles
Who Is Parag Agrawal? 8 Things to Know About Twitter’s New CEO.
Parag Agrawal is the new CEO of Twitter. Here's everything that investors should keep in mind as the social media giant moves forward. More
It’s a Good Time to Buy Square Stock While It’s Still on Sale
What will it take to get financial technology company Square's stock moving in the right direction again? The San Francisco-based digital payments company's stock has been slumping since the start of August and, at $196.90 a share, is now down 37.98% from its 52-week high of $289.23 reached on August 5. More
Short Squeeze Stocks: PPSI, NUZE and 3 Others Experts Think Are Ready to Pop
PPSI, NUZE, and three other stocks are ranked highly in Fintel's Short Squeeze Screener. All three names have a score higher than 96. More
The Lucid Rally Is Finally Stalling Out After Doubling in a Month
As the stock's growth slows, it may be time to short an overvalued and overbought LCID stock on any further strength with a bear call spread. More
